Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Atherosclerosis drugs Market to reach USD 4.4 billion by the end of 2030.

Global Atherosclerosis drugs Market Size study & Forecast, by Stages (Endothelial Damage and Immune Response, Fatty Streak, Plaque Growth, Plaque Rupture), by Diagnosis (Ankle-brachial Index, Doppler Ultrasound, Echocardiogram, Electrocardiogram, Blood Tests, Others), by Treatment (Medication, Surgery, Others), by Route of Administration (Oral, Parenteral, Others), by End-Users (Hospitals, Specialty Clinics, Homecare, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Analysis, 2023-2030

Product Code: HLSDT-33168629
Publish Date: 10-06-2023
Page: 200

Global Atherosclerosis drugs Market is valued approximately at USD 2.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.16% over the forecast period 2023-2030. Atherosclerosis drugs is a therapeutic category of medications used for the treatment of atherosclerosis and related cardiovascular diseases such as heart attacks, strokes, and peripheral vascular disease. This market growth is attributed to the high consumption of cholesterol-lowering drugs by patients to reduce or avoid blockages in arteries. The increasingly fast-paced lifestyle has depleted the ordinary person’s usual diet of essential nutrients that increases the risk of atherosclerosis, despite the age group and the growth rate of atherosclerosis market is the rising healthcare expenditure which helps in improving its infrastructure. The research and development in the healthcare sector have led to the production of effective atherosclerosis drugs globally.

Increasing the risk of atherosclerosis, the increased prevalence of obesity and high cholesterol is predicted to boost the market’s growth rate. According to estimates from the World Health Organisation (WHO) in 2020, 40 million children under the age of five were overweight or obese. Increased consumption of food high in fat and sugar as well as an increase in physical immobility brought on by the fact that many jobs are becoming less physically demanding, changing transportation options and growing urbanization are the factors that contributes to high cholesterol rates in people that are driving the market’s rapid expansion. Moreover, the market’s growth is fueled by an increase in the number of research and development activities also the integration of e-Commerce and the healthcare sector will generate considerable sales potential through online pharmacies for companies in the atherosclerosis medicines market. However, Side effects of drugs and the availability of generic products are the factors expected to restrain the market growth during the forecast period.

The key regions considered for the Global Atherosclerosis drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 holding the largest market share owing to the increased frequency of atherosclerosis and technical improvement in the treatment in this region. Furthermore, increased healthcare expenditure and the presence of significant key players would drive the market development rate in this area. According to the National Centre for Chronic Disease Prevention and Health Promotion’s Division for Heart Disease and Stroke Prevention, which was updated in July 2022, one person dies from cardiovascular disease every 34 seconds in the United States. Asia Pacific is expected to grow significantly during the forecast period, owing to the growing elderly population in this area and the rising level of disposable income. Additionally, the expansion of the healthcare sector’s infrastructure and growing government efforts will accelerate the market’s expansion in this area.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Merck & Co
Allergan Plc

Recent Developments in the Market:
Ø In September 2022, Novo Nordisk has entered into a new strategic cooperation with Microsoft to accelerate medication research and development via the use of big data and artificial intelligence (AI). The team will employ artificial intelligence to construct models that can predict a person’s risk of getting atherosclerosis or arterial plaque development. The researchers will also look for new atherosclerosis targets and indicators.
Ø In August 2022, AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that the European Commission (EC) has approved LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline BRCA1/2 mutations (gBRCAm) and HER2-negative high-risk early breast cancer who have previously received neoadjuvant or adjuvant chemotherapy.

Global Atherosclerosis drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Stages, Diagnosis, Treatment, Route of Administration, End-Users, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Stages:
Endothelial Damage and Immune Response
Fatty Streak
Plaque Growth
Plaque Rupture

By Diagnosis:
Ankle-brachial Index
Doppler Ultrasound
Blood Tests

By Treatment:

By Route of Administration:

By End-Users:
Specialty Clinics

By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Atherosclerosis drugs Market, by region, 2020-2030 (USD Billion)
1.2.2. Atherosclerosis drugs Market, by Stages, 2020-2030 (USD Billion)
1.2.3. Atherosclerosis drugs Market, by Diagnosis, 2020-2030 (USD Billion)
1.2.4. Atherosclerosis drugs Market, by Treatment, 2020-2030 (USD Billion)
1.2.5. Atherosclerosis drugs Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Atherosclerosis drugs Market, by End-User, 2020-2030 (USD Billion)
1.2.7. Atherosclerosis drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Atherosclerosis drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Atherosclerosis drugs Market Dynamics
3.1. Atherosclerosis drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing investment in healthcare infrastructure Growing Geriatric Population
3.1.2. Market Challenges High Cost and low diagnostic rates Side effects of drugs
3.1.3. Market Opportunities Increase in the number of research and development activities Government initiatives have been essential in raising the standard of healthcare services and infrastructure
Chapter 4. Global Atherosclerosis drugs Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Atherosclerosis drugs Market, by Stages
5.1. Market Snapshot
5.2. Global Atherosclerosis drugs Market by Stages, Performance – Potential Analysis
5.3. Global Atherosclerosis drugs Market Estimates & Forecasts by Stages 2020-2030 (USD Billion)
5.4. Atherosclerosis drugs Market, Sub Segment Analysis
5.4.1. Endothelial Damage and Immune Response
5.4.2. Fatty Streak
5.4.3. Plaque Growth
5.4.4. Plaque Rupture
Chapter 6. Global Atherosclerosis drugs Market, by Diagnosis
6.1. Market Snapshot
6.2. Global Atherosclerosis drugs Market by Diagnosis, Performance – Potential Analysis
6.3. Global Atherosclerosis drugs Market Estimates & Forecasts by Diagnosis 2020-2030 (USD Billion)
6.4. Atherosclerosis drugs Market, Sub Segment Analysis
6.4.1. Ankle-brachial Index
6.4.2. Doppler Ultrasound
6.4.3. Echocardiogram
6.4.4. Electrocardiogram
6.4.5. Blood Tests
6.4.6. Others
Chapter 7. Global Atherosclerosis drugs Market, by Treatment
7.1. Market Snapshot
7.2. Global Atherosclerosis drugs Market by Treatment, Performance – Potential Analysis
7.3. Global Atherosclerosis drugs Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
7.4. Atherosclerosis drugs Market, Sub Segment Analysis
7.4.1. Medication
7.4.2. Surgery
7.4.3. Others
Chapter 8. Global Atherosclerosis drugs Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Atherosclerosis drugs Market by Route of Administration, Performance – Potential Analysis
8.3. Global Atherosclerosis drugs Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Atherosclerosis drugs Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Others
Chapter 9. Global Atherosclerosis drugs Market, by End-User
9.1. Market Snapshot
9.2. Global Atherosclerosis drugs Market by End-User, Performance – Potential Analysis
9.3. Global Atherosclerosis drugs Market Estimates & Forecasts by End-User2020-2030 (USD Billion)
9.4. Atherosclerosis drugs Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Specialty Clinics
9.4.3. Homecare
9.4.4. Others
Chapter 10. Global Atherosclerosis drugs Market, by Distribution Channel
10.1. Market Snapshot
10.2. Global Atherosclerosis drugs Market by Distribution Channel, Performance – Potential Analysis
10.3. Global Atherosclerosis drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
10.4. Atherosclerosis drugs Market, Sub Segment Analysis
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.4.4. Others

Chapter 11. Global Atherosclerosis drugs Market, Regional Analysis
11.1. Top Leading Countries
11.2. Top Emerging Countries
11.3. Atherosclerosis drugs Market, Regional Market Snapshot
11.4. North America Atherosclerosis Drugs Market
11.4.1. U.S. Atherosclerosis drugs Market Stages breakdown estimates & forecasts, 2020-2030 Diagnosis breakdown estimates & forecasts, 2020-2030 Treatment breakdown estimates & forecasts, 2020-2030 Route of Administration breakdown estimates & forecasts, 2020-2030 End-User breakdown estimates & forecasts, 2020-2030 Distribution Channel breakdown estimates & forecasts, 2020-2030
11.4.2. Canada Atherosclerosis drugs Market
11.5. Europe Atherosclerosis drugs Market Snapshot
11.5.1. U.K. Atherosclerosis drugs Market
11.5.2. Germany Atherosclerosis drugs Market
11.5.3. France Atherosclerosis drugs Market
11.5.4. Spain Atherosclerosis drugs Market
11.5.5. Italy Atherosclerosis drugs Market
11.5.6. Rest of Europe Atherosclerosis drugs Market
11.6. Asia-Pacific Atherosclerosis drugs Market Snapshot
11.6.1. China Atherosclerosis drugs Market
11.6.2. India Atherosclerosis drugs Market
11.6.3. Japan Atherosclerosis drugs Market
11.6.4. Australia Atherosclerosis drugs Market
11.6.5. South Korea Atherosclerosis drugs Market
11.6.6. Rest of Asia Pacific Atherosclerosis Drugs Market
11.7. Latin America Atherosclerosis drugs Market Snapshot
11.7.1. Brazil Atherosclerosis drugs Market
11.7.2. Mexico Atherosclerosis drugs Market
11.8. Middle East & Africa Atherosclerosis drugs Market
11.8.1. Saudi Arabia Atherosclerosis drugs Market
11.8.2. South Africa Atherosclerosis drugs Market
11.8.3. Rest of Middle East & Africa Atherosclerosis drugs Market

Chapter 12. Competitive Intelligence
12.1. Key Company SWOT Analysis
12.1.1. Company 1
12.1.2. Company 2
12.1.3. Company 3
12.2. Top Market Strategies
12.3. Company Profiles
12.3.1. F. Hoffmann-La Roche Ltd. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
12.3.2. Mylan N.V.
12.3.3. Teva Pharmaceutical Industries Ltd.
12.3.4. Sanofi India
12.3.5. Pfizer Inc.
12.3.6. GlaxoSmithKline plc
12.3.7. Novartis AG
12.3.8. Merck & Co
12.3.9. Allergan India Pvt Ltd.
12.3.10. AstraZeneca
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now